Supplemental figure 5 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer

Authors :: Shunqiang Li
Donald P. McDonnell
John D. Norris
Jin-Ping Lai
Robert Crowder
Jieya Shao
Elizabeth Griffin
Tina Primeau
Kim T. Arndt
Stephen G. Dann
Todd VanArsdale
Koleen Eisele
Holly M. Alley
Matthew J. Ellis
Suzanne E. Wardell
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental figure 5: IHC analysis of treated PDX tumors indicated on-target activity of bazedoxifene and palbociclib

Full Text Access

Tools